ETFs bioMérieux

BIM

FR0013280286

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris Other stock markets 16:55:00 09/07/2025 BST			After hours 20:16:03
119.70 ^EUR	+0.59%		120.15	+0.38%

06-16	BioMérieux S.A. acquired Key Assets of Day Zero Diagnostics Inc.	CI
06-16	BioMérieux: agreement to acquire Day Zero Diagnostic	CF

ETFs positioned on bioMérieux

Name	Weight	AuM	1st Jan change
HARTFORD MULTIFACTOR DEVELOPED MARKETS (EX-US) ETF - USD	0.26%	1,022 M€	+20.23%	-
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY	0.17%	21 M€	+3.63%	-
AMUNDI INDEX MSCI WORLD SRI PAB - UCITS ETF DR (C) - EUR	0.05%	0 M€	-.--%	-
AMUNDI INDEX MSCI WORLD SRI PAB - UCITS ETF DR - HEDGED EUR (C)	0.05%	0 M€	-.--%	-
UBS (IRL) ETF PLC MSCI EUROPE ESG UNIVERSAL LOW CARBON SELECT UCITS ETF - ACC - EUR	0.05%	0 M€	-.--%	-
DAY HAGAN/NED DAVIS RESEARCH SMART SECTOR INTERNATIONAL ETF - USD	0.03%	32 M€	+14.66%	-
LYXOR NET ZERO 2050 S&P WORLD CLIMATE PAB (DR) UCITS ETF - ACC - USD	0.02%	0 M€	-.--%	-
VANGUARD INTERNATIONAL EQUITY INDEX FUNDS - VANGUARD FTSE ALL-WORLD EX-US ETF	0.02%	33,076 M€	+11.29%	-
AMUNDI MSCI WORLD CLIMATE PARIS ALIGNED PAB UCITS ETF DR (C) - USD	0.01%	0 M€	-.--%	-
AMUNDI MSCI WORLD CLIMATE TRANSITION CTB - UCITS ETF DR (C) - USD	0.01%	0 M€	-.--%	-
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (UNHEDGED) ETF - JPY	0.01%	331 M€	+0.35%	-
AMUNDI INDEX MSCI WORLD - UCITS ETF DR (C) - EUR	0.01%	0 M€	-.--%	-
AMUNDI INDEX MSCI WORLD UCITS ETF DR (D) - EUR	0.01%	0 M€	-.--%	-
RAREVIEW SYSTEMATIC EQUITY ETF - USD	0.01%	59 M€	+6.02%	-
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF ACC - EUR	0.01%	619 M€	-1.54%	-
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF - DISTRIBUTING - EUR	0%	53 M€	-2.05%	-
VANGUARD LIFESTRATEGY 60% EQUITY UCITS ETF - ACC - EUR	0%	467 M€	-0.44%	-
VANGUARD LIFESTRATEGY 60% EQUITY UCITS ETF - DISTRIBUTING - EUR	0%	61 M€	-1.37%	-

1 2

bioMérieux designs, develops, produces, and sells systems used in clinical practice to diagnose infectious diseases (including HIV, tuberculosis, and respiratory infections), cancers, and cardiovascular pathologies based on a biological sample (blood, saliva, urine, etc.). Net sales break down by sector of application as follows: - medical applications (84.8%): in industry, microbiological testing of samples from finished products, materials during the manufacturing process, or the environment, primarily in the food-processing, pharmaceutical, and cosmetics sectors; - industrial applications (15.2%). The group's diagnostic systems consist of three elements with related services: reagents, instruments (or platforms or analyzers), software, and services. Net sales are distributed geographically as follows: Europe/Middle East/Africa (31.9%), North America (45%), Asia/Pacific (16,5%) and Latin America (6.6%).

Employees

14,451

Sector

Medical Equipment, Supplies & Distribution

Calendar

09-03 - Q2 2025 Earnings Release

More about the company